CorNova revealed yesterday (23rd June) that it has received CE mark approval for its next-generation cobalt-chromium bare metal stent.

The company has developed an endovascular product known as Valecor Platinum, which delivers a new form of ion-based implantation technology for patients.

By offering a pure platinum surface on the lumen and artery wall, it can shield them from the less biocompatible elements that characterise alloys normally used for medical purposes.

"The Valecor Platinum Coronary Stent System represents a major advancement over current offerings in the relatively undifferentiated $1 billion bare stent market," said S Eric Ryan, CorNova Managing Director, Chairman and Chief Executive.

In addition, the stent contains some of the thinnest struts available at present and has a new open cell design which is capable of reducing inflammation and tissue damage in patients.

"Because of its highly biocompatible platinum surface and its novel open cell design, it has shown superior anti-restentotic performance compared to leading bare metal stents in preclinical studies," added Mr Ryan.

CorNova has also designed FiberHalo, a post-dilation angioplasty balloon catheter which offers stent lumen measurements within the confines of the catheter itself.

Source:

CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System (23/06/09)

Ÿ Adfero Ltd